Display options
Cite
Chen TW. Paths toward hepatitis B immunization in South Korea and Taiwan. Clin Exp Vaccine Res. 2013;2(2):76-82doi: 10.7774/cevr.2013.2.2.76.
Chen, T. W. (2013). Paths toward hepatitis B immunization in South Korea and Taiwan. Clinical and experimental vaccine research, 2(2), 76-82. https://doi.org/10.7774/cevr.2013.2.2.76
Chen, Tzung-Wen. "Paths toward hepatitis B immunization in South Korea and Taiwan." Clinical and experimental vaccine research vol. 2,2 (2013): 76-82. doi: https://doi.org/10.7774/cevr.2013.2.2.76
Chen TW. Paths toward hepatitis B immunization in South Korea and Taiwan. Clin Exp Vaccine Res. 2013 Jul;2(2):76-82. doi: 10.7774/cevr.2013.2.2.76. Epub 2013 Jul 03. PMID: 23858397; PMCID: PMC3710927.
Copy Download .nbib Format: NLM
Share it on

Clin Exp Vaccine Res. 2013 Jul;2(2):76-82. doi: 10.7774/cevr.2013.2.2.76. Epub 2013 Jul 03.

Paths toward hepatitis B immunization in South Korea and Taiwan.

Clinical and experimental vaccine research

Tzung-Wen Chen

Affiliations

  1. Department of Sociology, National Cheng-chi University, Taipei, Taiwan.

PMID: 23858397 PMCID: PMC3710927 DOI: 10.7774/cevr.2013.2.2.76

Abstract

South Korea and Taiwan have had similar experiences of economic development in the post-war era. The two societies have also successfully overcome the threat of liver cancer by using mass hepatitis B vaccinations. However, to reach their current states, they followed different directions, and experienced differing effects on their national health governance systems. In South Korea, vaccine production occurred prior to effectively introducing immunization programs. In contrast, Taiwan established an effective immunization program first. However, industrialization of vaccines against hepatitis B has failed. Taiwan has to import vaccines for domestic use. This article provides a contextual overview on the different methods South Korea and Taiwan have used to arrive at their modern status of hepatitis B immunization.

Keywords: Hepatitis B vaccines; Immunization programs; Industrialization of vaccine; Republic of Korea; Taiwan

References

  1. Am J Public Health. 2010 May;100(5):896-903 - PubMed
  2. Intervirology. 2010;53(1):20-8 - PubMed
  3. JAMA. 1987 May 15;257(19):2597-603 - PubMed
  4. J Clin Invest. 1973 May;52(5):1176-86 - PubMed
  5. N Engl J Med. 1997 Jun 26;336(26):1855-9 - PubMed
  6. Curr Top Microbiol Immunol. 2006;304:115-29 - PubMed
  7. Taiwan Yi Xue Hui Za Zhi. 1971 Feb 28;70(2):55-62 - PubMed
  8. Clin Exp Vaccine Res. 2012 Jul;1(1):3-8 - PubMed

Publication Types